Login / Signup

Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia.

Zachary BraunsteinEric McLaughlinAnjali MishraJonathan E Brammer
Published in: Blood advances (2022)
Keyphrases
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • low dose
  • multiple myeloma
  • diffuse large b cell lymphoma
  • bone marrow
  • high dose
  • hodgkin lymphoma
  • single molecule